Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

NCT03911531 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03911531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03911531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops
Lead sponsor
Thomas Jefferson University
Phase
Observational
Overall status
Completed
Start date
January 15, 2019
Completion date
December 31, 2025
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disorders, nonimmune fetal hydrops, nonimmune hydrops in neonate